A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Collection of Serum- and Feeder-free Mouse Embryonic Stem Cell-conditioned Medium for a Cell-free Approach

10.3K views

⸱

DOI:

10.3791/55035

⸱

January 8th, 2017

 ,  , 

In This Article

Summary

This protocol provides a method for the collection of mouse embryonic stem cell (mESC)-conditioned medium (mESC-CM) derived from serum (fetal bovine serum, FBS)- and feeder (mouse embryonic fibroblasts, MEFs)-free conditions for a cell-free approach. It may be applicable for the treatment of aging and aging-associated diseases.

Abstract

The capacity of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to generate various cell types has opened new avenues in the field of regenerative medicine. However, despite their benefits, the tumorigenic potential of ESCs and iPSCs has long been a barrier for clinical applications. Interestingly, it has been shown that ESCs produce several soluble factors that can promote tissue regeneration and delay cellular aging, suggesting that ESCs and iPSCs can also be utilized as a cell-free intervention method. Therefore, the method for harvesting mouse embryonic stem cell (mESC)-conditioned medium (mESC-CM) with minimal contamination of serum components (fetal bovine serum, FBS) and feeder cells (mouse embryonic fibroblasts, MEFs) has been highly demanded. Here, the present study demonstrates an optimized method for the collection of mESC-CM under serum- and feeder-free conditions and for the characterization of mESC-CM using senescence-associated multiple readouts. This protocol will provide a method to collect pure mESC-specific secretory factors without serum and feeder contamination.

Introduction

The goal of this protocol is to collect mouse embryonic stem cell (mESC)-conditioned medium (mESC-CM) from serum- and feeder-free culture conditions and to characterize its biological functions.

In general, embryonic stem cells (ESCs) have great potential for regenerative medicine and cell therapy due to their pluripotency and capacity for self-renewal1-3. However, the direct transplantation of stem cells has several limitations, such as immune rejection and tumor formation4,5. Therefore, a cell-free approach may provide an alternate therapeutic strategy for regenerative medicine and aging interventions6,7.<....

Access restricted. Please log in or start a trial to view this content.

Protocol

NOTE: A schematic of the serum- and feeder-free CM collection protocol is shown in Figure 1.

1. Materials (Preparation of MEFs, Medium, Plates, and Solutions)

  1. Prepare 500 ml of medium to culture the MEFs. Supplement Dulbecco's Modified Eagle's Medium (DMEM) with 10% FBS (ESC quality), 50 units/ml penicillin, and 50 mg/ml streptomycin.
  2. Isolate MEFs from embryos following an established routine protocol13 and maintain them in MEF medium.
  3. Prepare 500 ml of medium to culture the mESCs. DMEM is supplemented with 15% FBS and 2 mM L-glutamine, 100 µM non-essential amino acids (NEAA), 100 µM ....

Access restricted. Please log in or start a trial to view this content.

Results

Originally, mESCs are maintained on an MEF feeder in mESC medium with FBS and other supplements (Figures 1A and 2A). CM was collected from mESCs in Reduced Serum Media without a feeder layer, FBS, or other supplements (Figures 1B and 2B). This culture condition allows us to collect mESC-specific conditioned medium without potential contamination by the factors from the feeder, FBS, or other supplements. The control medium.......

Access restricted. Please log in or start a trial to view this content.

Discussion

For the successful collection of serum- and feeder-free mESC-CM, the following suggestions should be taken into consideration. The most critical factor is using early passage mESCs for the collection of mESC-CM. Previously, it has been shown that early passage mESC-CM has better anti-aging effects compared to late passage mESCs. The passage number of mESCs has been reported to affect their developmental potential16 and pluripotency17.

While additional research is needed t.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

This research was supported by the Basic Science Research Program (2013R1A1A2060930) and the Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF), funded by the Ministry of Science, ICT, and Future Planning. This research is also supported by a Start-up Operating Grant from The Hospital for Sick Children (H. K. Sung). We would like to thank Laura Barwell and Sarah J. S. Kim for their excellent help in editing this manuscript and Dr. Andras Nagy for providing the G4 mESC line.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
DMEMInvitrogen#11960-044
FBSInvitrogen#3004433320%, ES cell quality
Penicillin and streptomycinInvitrogen#1514050 units/ml penicillin and 50 mg/ml streptomycin
L-glutamineInvitrogen#250302 mM
Nonessential amino acids (NEAA)Invitrogen#11140100 µM
β-mercaptoethanol Sigma#M3148100 µM
Leukemia inhibitory factor Millipore#ESG1107100 units/ml
OPTI-MEMInvitrogen#22600
X-gal Sigma#B42521 mg/ml
Paraformaldehyde (PFA)SigmaP61483.70%
Dimethylformamide (DMF)Sigma#D4551
Potassium ferricyanideAldrich#4559465 mM
potassium ferrocyanideAldrich#4559895 mM
NaClSigma#S7653150 mM
MgCl2Sigma#M23932 mM
Mitomycin CSigma#M428710 µg/ml
Propidium iodide Sigma#P417050 µg/ml
TRIzolAmbion#15596018
M-MLV reverse transcript-tasePromega#M170B
Power SYBR Green PCR master mix Applied Biosystems#4367659
HDFs, NHDF-Ad-Der-Fibroblast LONZA#CC-2511
Bottle top filterCorning#4305130.2 μm

References

  1. Thomson, J. A., et al. Embryonic stem cell lines derived from human blastocysts. Science. 282, 1145-1147 (1998).
  2. Lavasani, M., et al. Muscle-derived stem/progenitor cell dysfunction limits healthspan and lifespan in a murine progeria model.

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Explore More Articles

Mouse Embryonic Stem CellsSerum-free CultureFeeder-free Conditioned MediumSenescence-associated Beta Galactosidase AssayFlow Cytometry AnalysisQuantitative Reverse Transcriptase PCRHuman Dermal FibroblastsCell Cycle AnalysisRNA Extraction KitReal-time PCR Machine